Literature DB >> 7660342

Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.

I M Garrelds1, J G van Amsterdam, C de Graaf-in't Veld, R Gerth van Wijk, F J Zijlstra.   

Abstract

BACKGROUND: The role of nitric oxide in the early and late phase of the allergic process was investigated in patients with allergic rhinitis against house dust mite and the effect of fluticasone propionate aqueous nasal spray was determined.
METHODS: Production of nitric oxide (measured as nitrite+nitrate) in vivo in nasal mucosa was examined in 24 patients with rhinitis allergic to the house dust mite. In a double blind placebo controlled crossover study fluticasone propionate 200 micrograms aqueous nasal spray was administered twice daily for two weeks. In response to provocation with house dust mite extract (after four basal nasal lavages) nasal lavages were performed every hour for 9.5 hours by washing the nose with saline. In addition, a similar lavage protocol was performed in healthy volunteers with or without challenge with phosphate buffered saline.
RESULTS: Nitric oxide is present in nasal lavage fluid in detectable amounts (range 10-50 microM), the level gradually increasing with time in both patients and controls after a decrease during the four basal lavages. Treatment with fluticasone propionate aqueous nasal spray did not affect initial basal production of nitric oxide nor production following provocation with house dust mite extract.
CONCLUSIONS: Production of nitric oxide in nasal mucosa determined in sequential nasal washings is not affected by therapeutic doses of intranasal steroids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660342      PMCID: PMC1021192          DOI: 10.1136/thx.50.3.275

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages.

Authors:  M Di Rosa; M Radomski; R Carnuccio; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 3.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

4.  The cellular response of the human allergic mucosa to natural allergen exposure.

Authors:  U Pipkorn; G Karlsson; L Enerback
Journal:  J Allergy Clin Immunol       Date:  1988-12       Impact factor: 10.793

5.  Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide.

Authors:  C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.

Authors:  R G Knowles; M Salter; S L Brooks; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

7.  L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages.

Authors:  P G Jorens; F J Van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

Review 8.  Neural mechanisms in asthma.

Authors:  P J Barnes
Journal:  Br Med Bull       Date:  1992-01       Impact factor: 4.291

9.  Structure-activity relationships of topically active steroids: the selection of fluticasone propionate.

Authors:  G H Phillipps
Journal:  Respir Med       Date:  1990-11       Impact factor: 3.415

10.  The effects of topical fluticasone propionate on allergen-induced immediate nasal airways response and eosinophil activation: preliminary results.

Authors:  K E Thomas; L Greenwood; N Murrant; J Cook; J L Devalia; R J Davies
Journal:  Respir Med       Date:  1990-11       Impact factor: 3.415

View more
  5 in total

1.  Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.

Authors:  P J Turner; J R Maggs; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Exhaled nitric oxide: a new lung function test.

Authors:  P J Barnes; S A Kharitonov
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 3.  Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.

Authors:  P J Turner; J C Foreman
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

4.  Nasal hyperreactivity and inflammation in allergic rhinitis.

Authors:  I M Garrelds; C de G Veld; R G Wijk; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

5.  Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis.

Authors:  A P Dijk; Z J Keuskamp; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.